Blog

USC Ginsburg Institute researchers help lead development of precision drug delivery tool to treat traumatic brain injury

By Alexandra Demetriou An interdisciplinary team of researchers at the University of Southern California has developed a precision drug delivery tool to selectively treat areas of the brain damaged during a traumatic brain injury (TBI). The researchers anticipate that their rapidly deployable intervention could potentially help prevent long-term brain damage in the millions of Americans […]

Mark Humayun, MD, PhD Receives 25th Annual Gertrude D. Pyron Award

By Alexandra Demetriou Mark Humayun, MD, PhD was recently awarded the Retina Research Foundation’s 25th Annual Gertrude D. Pyron Award. According to the Retina Research Foundation, this honor is bestowed upon “outstanding vision scientists whose work contributes to knowledge about vitreoretinal disease.” Humayun, a prolific inventor, is widely recognized for his substantial and lasting contributions […]

USC researchers bioengineer first-line defense against COVID-19

By Alexandra Demetriou Researchers at the USC Dr. Allen and Charlotte Ginsburg Institute for Biomedical Therapeutics, the USC Institute for Technology and Medical Systems and the USC School of Pharmacy are developing an antimicrobial fluid to bolster the body’s first-line defenses against COVID-19. The biocompatible coating is intended to block the virus from entering the […]

Mark Humayun wins IEEE Medal for Innovations in Healthcare Technology

By Alexandra Demetriou Mark Humayun, MD, PhD, director of the USC Dr. Allen and Charlotte Ginsburg Institute for Biomedical Therapeutics and co-director of the USC Roski Eye Institute, was awarded the 2020 Medal for Innovations in Healthcare Technology by the Institute of Electrical and Electronics Engineers (IEEE) on Friday night. Mark Humayun, MD, PhD (Photo credit: USC Roski Eye Institute) The […]

Physician-scientists pioneer new surgical approach to treat progressive blindness

By Alexandra Demetriou Dry age-related macular degeneration (dry AMD) poses a significant clinical challenge. It is one of the leading causes of progressive blindness, robbing millions of people over the age of 65 of their central vision, and it often hinders patients’ abilities to read books, drive and discern the faces of their loved ones. […]

USC Ginsburg Institute researchers receive NSF funding to develop contact lens that uses electric stimulation to heal retina

By Alexandra Demetriou The National Science Foundation recently awarded an Emerging Frontiers in Research and Innovation (EFRI) grant of $1,999,999 to Mark Humayun, MD, PhD, director of the USC Dr. Allen and Charlotte Ginsburg Institute for Biomedical Therapeutics and co-director of the USC Roski Eye Institute. The grant will support an innovative and multidisciplinary project combining engineering and […]

Science fiction to science fact: Mark Humayun, MD, PhD, talks cutting-edge science, family history, and dedication to curing blindness on Spectrum News

By Alexandra Demetriou Mark Humayun, MD, PhD, was featured in an episode of LA Stories with Giselle Fernandez, an Emmy Award-winning series on Spectrum News 1 dedicated to highlighting the “change agents” of Southern California who are shaping the future and imparting lasting changes on our community. Humayun, who serves as director of the USC […]

Mark Humayun, MD, PhD and Amir Kashani, MD, PhD featured in Voice of America “VOA/TEK” episode highlighting their mission to restore sight

By Alexandra Demetriou  Mark Humayun, MD, PhD and Amir Kashani, MD, PhD were featured on Voice of America’s “VOA/TEK,” a news program dedicated to highlighting the most cutting-edge technologies and medical breakthroughs around the world. The episode details the strides Humayun and his team have made in their mission to restore sight, the lasting impact […]

Economic analysis shows treatment for wet age-related macular degeneration generates billions of dollars in societal value

By Alexandra Demetriou Researchers at the University of Southern California have developed an economic model to quantify the benefits of treatment for wet age-related macular degeneration (wAMD), the leading cause of blindness in western countries. Their work signals a step forward in the way ophthalmologists audit their practices to define the worth of modern treatments […]